The American company Synchron plans to begin testing with brain chip implants in six patients at a hospital in New York.
Synchron has already received approval from the relevant authorities (FDA) to conduct clinical trials of a neurochip that will connect the brain and the computer, Bloomberg reports. This after having previously tested the device on four volunteers in Australia.
The main task of the innovative implant in the human brain, called Stentrode, is to help paralyzed people control various digital devices using the power of thought.
Using a thin wire, the chip implanted in the brain is connected to an implant located in the chest. It is important to note that Stentrode connects to the body without surgery, that is, with penetration through the blood vessels at the base of the neck. All the procedures involved in this installation take about two hours.
Interestingly, according to the publication, this project is funded by the United States Department of Defense, which may indicate the department’s long-range plans for this development.
Work in this direction has been going on in the world for a long time, and scientists are interested in creating a brain-machine interface with the least interference in the human body. For now, the biggest concerns lie with cybersecurity.
“There are a variety of security concerns that haven’t been addressed before, which is a big part of the discussions we’ve had,” said Synchron CEO Thomas Oxley.
If the study is successful, this brain implant could reach the next step in the approval process, with an estimate of the product available on the market in the next three to five years.